ANI Pharmaceuticals, Inc. (ANIP)
74.27
+2.10
(+2.91%)
USD |
NASDAQ |
Mar 17, 16:00
74.27
0.00 (0.00%)
After-Hours: 16:19
ANI Pharmaceuticals Profit Margin (Quarterly) : 10.28% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CorMedix, Inc. | 10.90% |
| Castle Biosciences, Inc. | -2.68% |
| Allogene Therapeutics, Inc. | -- |
| Catalyst Pharmaceuticals, Inc. | 34.53% |
| Assertio Holdings, Inc. | 23.14% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.48% |
| Return on Assets | 5.27% |
| Return on Invested Capital | 6.48% |
| Gross Profit Margin (Quarterly) | 50.26% |
| Operating Margin (Quarterly) | 11.79% |
| Return on Net Operating Assets | 6.16% |